Victoria R Votaw1, Rachel Geyer2, Maya M Rieselbach3, R Kathryn McHugh4. 1. Department of Psychology, University of New Mexico, MSC 03-2220, Albuquerque, NM, USA. Electronic address: vvotaw@unm.edu. 2. Division of Alcohol and Drug Abuse, McLean Hospital, 115 Mill Street, Belmont, MA, USA. 3. Department of Psychiatry, McLean Hospital, 115 Mill Street, Belmont, MA, USA. 4. Division of Alcohol and Drug Abuse, McLean Hospital, 115 Mill Street, Belmont, MA, USA; Department of Psychiatry, Harvard Medical School, 401 Park Drive, Boston, MA, USA.
Abstract
BACKGROUND: Benzodiazepine misuse is a growing public health problem, with increases in benzodiazepine-related overdose deaths and emergency room visits in recent years. However, relatively little attention has been paid to this emergent problem. We systematically reviewed epidemiological studies on benzodiazepine misuse to identify key findings, limitations, and future directions for research. METHODS: PubMed and PsychINFO databases were searched through February 2019 for peer-reviewed publications on benzodiazepine misuse (e.g., use without a prescription; at a higher frequency or dose than prescribed). Eligibility criteria included human studies that focused on the prevalence, trends, correlates, motives, patterns, sources, and consequences of benzodiazepine misuse. RESULTS: The search identified 1970 publications, and 351 articles were eligible for data extraction and inclusion. In 2017, benzodiazepines and other tranquilizers were the third most commonly misused illicit or prescription drug in the U.S. (approximately 2.2% of the population). Worldwide rates of misuse appear to be similar to those reported in the U.S. Factors associated with misuse include other substance use, receipt of a benzodiazepine prescription, and psychiatric symptoms and disorders. Benzodiazepine misuse encompasses heterogeneous presentations of motives, patterns, and sources. Moreover, misuse is associated with myriad poor outcomes, including mortality, HIV/HCV risk behaviors, poor self-reported quality of life, criminality, and continued substance use during treatment. CONCLUSIONS: Benzodiazepine misuse is a worldwide public health concern that is associated with a number of concerning consequences. Findings from the present review have implications for identifying subgroups who could benefit from prevention and treatment efforts, critical points for intervention, and treatment targets.
BACKGROUND:Benzodiazepine misuse is a growing public health problem, with increases in benzodiazepine-related overdose deaths and emergency room visits in recent years. However, relatively little attention has been paid to this emergent problem. We systematically reviewed epidemiological studies on benzodiazepine misuse to identify key findings, limitations, and future directions for research. METHODS: PubMed and PsychINFO databases were searched through February 2019 for peer-reviewed publications on benzodiazepine misuse (e.g., use without a prescription; at a higher frequency or dose than prescribed). Eligibility criteria included human studies that focused on the prevalence, trends, correlates, motives, patterns, sources, and consequences of benzodiazepine misuse. RESULTS: The search identified 1970 publications, and 351 articles were eligible for data extraction and inclusion. In 2017, benzodiazepines and other tranquilizers were the third most commonly misused illicit or prescription drug in the U.S. (approximately 2.2% of the population). Worldwide rates of misuse appear to be similar to those reported in the U.S. Factors associated with misuse include other substance use, receipt of a benzodiazepine prescription, and psychiatric symptoms and disorders. Benzodiazepine misuse encompasses heterogeneous presentations of motives, patterns, and sources. Moreover, misuse is associated with myriad poor outcomes, including mortality, HIV/HCV risk behaviors, poor self-reported quality of life, criminality, and continued substance use during treatment. CONCLUSIONS:Benzodiazepine misuse is a worldwide public health concern that is associated with a number of concerning consequences. Findings from the present review have implications for identifying subgroups who could benefit from prevention and treatment efforts, critical points for intervention, and treatment targets.
Authors: Sean Esteban McCabe; Brady T West; Christian J Teter; Paula Ross-Durow; Amy Young; Carol J Boyd Journal: Drug Alcohol Depend Date: 2011-06-12 Impact factor: 4.492
Authors: Federica Daniela Vigna-Taglianti; Paola Burroni; Federica Mathis; Elisabetta Versino; Franca Beccaria; Mara Rotelli; Marina Garneri; Anna Picciolini; Anna Maria Bargagli Journal: Subst Use Misuse Date: 2016-02-12 Impact factor: 2.164
Authors: R Kathryn McHugh; Andrew D Peckham; Thröstur Björgvinsson; Francesca M Korte; Courtney Beard Journal: J Psychiatr Res Date: 2020-05-24 Impact factor: 4.791